Science About Us Ingredients Contact Join Waitlist →

The Gap

Cancer patients are being handed formulas that may unintentionally fuel tumor growth.

Conventional meal replacements were formulated decades ago to deliver calories for general malnutrition. They are built on sugar, maltodextrin, dairy protein and omega-6 oils, the same inputs that activate the insulin, IGF-1 and inflammatory pathways oncology spends its days working to calm. The result is a product that nourishes the patient and, at the same time, supplies the exact substrates that cancer metabolism thrives on. Metabolica is built the other way around. Every nutrient is chosen against the metabolic realities of cancer treatment and recovery.

Abstract microscopic biological imagery

The Approach

Six Coordinated Metabolic Levers

Metabolica was not designed in a vacuum. It is the work of a physician who has spent twenty-five years treating cancer patients in clinical practice, formalized into a formula that pulls six coordinated metabolic levers at once. Each lever addresses a specific way that cancer metabolism diverges from the metabolism of healthy tissue. The first four are shown below as live pathway models; two more shape how the formula behaves inside the body.

Metabolica's six coordinated metabolic levers Six labelled nodes arranged around a central core like a molecule, with accent particles orbiting the ring. 01 02 03 04 05 06 6 LEVERS GLUCOSE & IGF-1 KETONEENERGY GLUTAMINE& PROTEIN INFLAMMATION& REDOX MICRONUTRIENTS DIGESTION

01  Growth Signaling

Quieting the insulin, IGF-1 and mTOR axis.

Refined sugar, maltodextrin and dairy protein acutely raise glucose, insulin and IGF-1, driving the PI3K/AKT/mTOR cascade that promotes anabolic growth signaling and suppresses autophagy. Metabolica is designed to keep these inputs low.

Toggle to compare the signaling state of the pathway.
Conventional dietary inputs refined sugar · maltodextrin · casein / whey Metabolica inputs plant protein · agave inulin · MCT / BHB · zero sugar Insulin · IGF-1 pancreatic insulin · hepatic IGF-1 Membrane receptors IR · IGF-1R (RTKs) · IRS-1/2 PI3K, class I (α · β · γ · δ) activated via RTK / IRS-1 PIP2 → PIP3 PTEN PIP3 → PIP2 AKT PH domain binds PIP3 · pThr308 · pSer473 mTORC2 Rictor · mSin1 · mLST8 mTORC1 mTOR · Raptor · Rheb-GTP ACTIVATED mTORC1 mTOR · Raptor · Rheb-GTP RESTRAINED AMPK ↑ activated by berberine Amino acids leucine → Rag GTPases ↑ Protein synthesis S6K1 · 4E-BP1 / eIF4E Balanced synthesis S6K1 · 4E-BP1 ↑ Proliferation Cell maintenance Autophagy ↓ suppressed Autophagy preserved
Nodes signaling elevated
Outputs driven supported negative feedback

02  Cellular Energy

Fueling healthy cells with ketones, not glucose.

Many tumor cells rely on aerobic glycolysis, converting glucose to lactate even when oxygen is present. Healthy cells stay metabolically flexible and oxidize fat and ketones efficiently through the mitochondria. Metabolica supplies the second kind of fuel.

Healthy cell · flexible  |  glycolytic tumor cell
HEALTHY CELL · METABOLICALLY FLEXIBLE GLYCOLYTIC TUMOR CELL · WARBURG EFFECT MCT, C8 / C10 medium-chain fats BHB salts β-hydroxybutyrate β-oxidation CPT1 · FADH₂ BDH1 → acetoacetate → acetyl-CoA MITOCHONDRION TCA cycle · OXPHOS ETC complexes I–V Steady aerobic ATP ↑ NAD⁺/NADH · low ROS Glucose via GLUT1 transporter ↑ Aerobic glycolysis HK2 · PKM2 · LDHA glucose → pyruvate ↑ FLUX · RAPID ATP Lactate + biomass acidifies microenvironment Ketone oxidation limited low BDH1 in many tumors
Fuel ketone / fat glucose
Cell healthy · oxidative glycolytic tumor

03  Secondary Fuel & Anabolic Drive

Moderating glutamine flux and nitrogen load.

Glutamine is a key secondary fuel for many tumors, feeding the TCA cycle through glutaminolysis while supplying nitrogen for nucleotide synthesis. Dairy proteins rich in leucine and lysine further amplify anabolic, pro-growth signaling.

Toggle to see how flux and anabolic drive change.
Dairy protein high leucine · lysine · glutamine Rice + pea protein lower leucine · lysine · methionine Glutamine pool SLC1A5 transporter Leucine sensing Sestrin2 · Rag GTPases Glutaminase (GLS) glutamine → glutamate → α-KG TCA cycle anaplerosis mTORC1 ↑ ANABOLIC DRIVE mTORC1 RESTRAINED ↑ Nucleotide & GSH synthesis Moderated biosynthesis ↑ Muscle protein + tumor N Lean tissue preserved
Nodes metabolic step elevated
Outputs high flux / drive moderated · preserved

04  Inflammation & Redox

Calming inflammatory and oxidative signaling.

Omega-6 dominant seed oils raise arachidonic acid and prostaglandin E2, while excess iron and copper drive Fenton-reaction free radicals. Together they sustain NF-kB signaling and a pro-inflammatory, oxidative environment. Metabolica takes the opposite approach.

Toggle to calm the cascade.
Omega-6 seed oils corn · canola · soy → arachidonic acid MCT + botanicals no omega-6 · berberine · ginger · cinnamon Excess iron + copper Fenton reaction → free radicals Controlled micronutrients no added Fe/Cu · Zn · Se · Mn COX-2 → PGE2 prostaglandin signaling ROS · oxidative stress •OH · superoxide NF-κB ↑ ACTIVATED · COX-2 ↑ NF-κB BALANCED Berberine · ginger cinnamon · BHB ↑ IL-6 · TNF-α · IL-1β pro-inflammatory cytokines Lowered cytokines IL-6 · TNF-α moderated ↑ Oxidative stress SOD · GPx supported antioxidant enzymes Inflammatory microenvironment Lower inflammatory tone
Nodes mediator elevated botanical support
Outputs inflammatory supported / calmed

Two more levers

Engineered down to the micronutrient.

Beyond the four signaling pathways above, two further levers shape how the formula behaves in the body and in a chemo-affected gut.

05  Micronutrient Engineering

Minerals dosed to physiology, not habit.

Conventional formulas add iron, copper and high B12 by default. Excess iron drives oxidative stress through the Fenton reaction, and copper is associated with angiogenic signaling. Metabolica is dosed deliberately.

  • Iron held low, around 0.8 mg, with no added copper.
  • B12 at a physiologic 2.4 micrograms.
  • Physiologic zinc, selenium and manganese as antioxidant-enzyme cofactors.

06  Digestive Tolerance

Built for a gut under treatment.

Chemotherapy and radiation often leave the gut inflamed and poorly absorptive. Lactose, soy isolates and emulsifiers make that worse. Metabolica is formulated to be tolerated and absorbed.

  • Protease, lipase and carbohydrase to support absorption.
  • DGL and ginger for digestive comfort and antiemetic support.
  • Agave inulin as a gentle prebiotic fiber.

Supportive Care Protocols

One formula, every stage.

Metabolica is a flexible nutritional adjunct rather than a rigid 28-day protocol. The metabolic challenge changes across treatment and recovery, and so does the way the formula is used. Select a stage to see the dosing and rationale drawn from the whitepaper.

≈15 g rice + pea protein 0 g added sugar / maltodextrin Iron 0.8 mg, no added copper B12 2.4 µg physiologic MCT + BHB ketone energy

The Clinician's Formula

Built by a physician, not a lab.

Metabolica was formulated by Dr. Steve Rallis, DC, ND, who has spent twenty-five years in integrative oncology. Not modeling cells in a lab, but treating patients in his own clinic: ordering and interpreting blood work and metabolic markers, managing chemo-affected guts, and watching patients decline on sugar-and-dairy shakes. Every nutrient in the formula is justified, dosed to physiology, and considered for compatibility with treatment.

One hundred years of science, twenty-five years of clinical practice, an entire line of metabolically intelligent products.

Dr. Steve Rallis, DC, ND
Dr. Steve Rallis, DC, ND

Evidence & References

The full rationale, cited.

Every mechanism on this page is drawn from the Metabolica whitepaper, built on a thirty-three reference scientific base.

Important. Metabolica is a medical food intended to provide nutritional support and is not a drug. It is not intended to diagnose, treat, cure or prevent cancer or any disease. The pathway diagrams on this page describe the scientific rationale behind the formula's design and are provided for educational purposes only. Metabolica should be used under the supervision of a physician as part of a comprehensive care plan. These statements have not been evaluated by the Food and Drug Administration.